F081 Dermoscopy for the Non-dermoscopist
DESCRIPTION
Novice dermoscopists will be taught recognizable dermoscopic patterns to assist in the diagnosis of pigmented lesions. We will discuss a simple pattern recognition system that can be incorporated into routine dermatologic practice. The session will also include dermoscopy of special sites, including the face and acral surfaces. Participants will be shown unknown cases throughout the session for self-assessment and the approach to diagnosis of these cases will be reviewed. By incorporating dermoscopy into everyday practice, participants will be able to improve their diagnostic accuracy in detecting melanoma and other skin cancers.
LEARNING OBJECTIVES
Recognize characteristic dermoscopic structures of benign and malignant lesions.
Use dermoscopy to distinguish benign from suspicious lesions that require biopsy.
Use dermoscopy to distinguish benign from suspicious lesions that require biopsy.
SCHEDULE
9:00 AM
Introduction / Why I Should Learn Dermoscopy
Jennifer A. Stein, MD, PhD, FAAD
9:05 AM
Melanocytic Structures and Benign Patterns
Kelly C Nelson, MD, FAAD
9:20 AM
Melanoma
Elizabeth Gates Berry, MD, FAAD
9:35 AM
Non-melanocytic Patterns
Michelle B. Tarbox, MD, FAAD
9:55 AM
Face
Kendall Buchanan, MD, FAAD
10:10 AM
Acral / Mucosal
Jennifer A. Stein, MD, PhD, FAAD
10:25 AM
Cases / Kahoot quiz
Konstantinos Liopyris, MD
10:40 AM
Q+A
DIRECTOR
Jennifer A. Stein, MD, PhD, FAAD
SPEAKERS
Elizabeth Gates Berry, MD, FAAD
Kendall Buchanan, MD, FAAD
Konstantinos Liopyris, MD
Kelly C Nelson, MD, FAAD
Michelle B. Tarbox, MD, FAAD
HANDOUTS
DISCLOSURES
Elizabeth Gates Berry, MD, FAAD
Orlucent – Investigator(Grants/Research Funding);
Kendall Buchanan, MD, FAAD
DermaSensor Inc – Consultant (1099 relationship)(Fees); Dermlite, LLC – Other(Other Financial Benefit); Georgia Society for Dermatology and Dermatological Surgery – Investigator(Grants/Research Funding); MetaOptima – Consultant (1099 relationship)(Fees); Modern Ritual – Consultant (1099 relationship)(Fees);
Konstantinos Liopyris, MD
No financial relationships exist with ineligible companies.
Kelly C Nelson, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer A. Stein, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Michelle B. Tarbox, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermaleve – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);